The use of human adipose-derived stem cells based cytotoxicity assay for acute toxicity test
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 73 (3) , 992-998
Abstract
No abstract availableKeywords
Funding Information
- Fundação Oswaldo Cruz – FIOCRUZ
- CAPES/Fundação Araucária (309935/2012-1)
This publication has 15 references indexed in Scilit:
- Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitroWorld Journal of Stem Cells, 2014
- A method for rapid dose–response screening of environmental chemicals using human embryonic stem cellsJournal of Pharmacological and Toxicological Methods, 2012
- Induced pluripotent stem cells: the new patient?Nature Reviews Molecular Cell Biology, 2012
- Cytotoxicity and inhibitory effects of low-concentration triclosan on adipogenic differentiation of human mesenchymal stem cellsToxicology and Applied Pharmacology, 2012
- Stem cell technology for drug discovery and developmentDrug Discovery Today, 2012
- Alternative methods in toxicology: pre-validated and validated methodsInterdisciplinary Toxicology, 2011
- Proposal for a Brazilian centre on alternative test methodsALTEX, 2009
- Adipose-Derived Stem Cells for Regenerative MedicineCirculation Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The Registry of Cytotoxicity: Toxicity Testing in Cell Cultures to Predict Acute Toxicity (LD50) and to Reduce Testing in AnimalsAlternatives to Laboratory Animals, 2003